Evidence map›Paper›PMID 30719048›Full record

ArticleStem cells international2019

Skeletal Muscle Resident Progenitor Cells Coexpress Mesenchymal and Myogenic Markers and Are Not Affected by Chronic Heart Failure-Induced Dysregulations.

R I Dmitrieva, T A Lelyavina, M Y Komarova, V L Galenko, O A Ivanova, P A Tikanova, N V Khromova, A S Golovkin, M A Bortsova, A Sergushichev and 2 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. [The role of CD146 in mesenchymal stem cells].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

R I DmitrievaInstitute of Molecular Biology and Genetics, National Almazov Medical Research Centre, Saint Petersburg, Russia.ORCID 0000-0002-3073-7914
T A LelyavinaHeart Failure Department, National Almazov Medical Research Centre, Saint Petersburg, Russia.
M Y KomarovaPeter the Great St. Petersburg Polytechnic University, Saint Petersburg, Russia.
V L GalenkoHeart Failure Department, National Almazov Medical Research Centre, Saint Petersburg, Russia.
O A IvanovaITMO University, Saint Petersburg, Russia.
P A TikanovaSaint Petersburg State University, Saint Petersburg, Russia.
N V KhromovaInstitute of Molecular Biology and Genetics, National Almazov Medical Research Centre, Saint Petersburg, Russia.
A S GolovkinInstitute of Molecular Biology and Genetics, National Almazov Medical Research Centre, Saint Petersburg, Russia.ORCID 0000-0002-7577-628X
M A BortsovaHeart Failure Department, National Almazov Medical Research Centre, Saint Petersburg, Russia.
A SergushichevITMO University, Saint Petersburg, Russia.
M Yu SitnikovaHeart Failure Department, National Almazov Medical Research Centre, Saint Petersburg, Russia.
A A KostarevaInstitute of Molecular Biology and Genetics, National Almazov Medical Research Centre, Saint Petersburg, Russia.
Federal Almazov North-West Medical Research Centre · RUITMO University · RUPeter the Great St. Petersburg Polytechnic University · RUSt Petersburg University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeIn heart failure (HF), metabolic alterations induce skeletal muscle wasting and decrease of exercise capacity and quality of life. The activation of skeletal muscle regeneration potential is a prospective strategy to reduce muscle wasting; therefore, the aim of this project was to determine if functional properties of skeletal muscle mesenchymal progenitor cells (SM-MPC) were affected by HF-induced functional and metabolic dysregulations.

methodsGastrocnemius muscle biopsy samples were obtained from 3 healthy donors (HD) and 12 HF patients to purify mRNA for further analysis and to isolate SM-MPC. Cells were expanded in vitro and characterized by immunocytochemistry and flow cytometry for expression of mesenchymal (CD105/CD73/CD166/CD146/CD140b/CD140a/VIM) and myogenic (Myf5/CD56/MyoG) markers. Cells were induced to differentiate and were then analyzed by immunostaining and Q-PCR to verify the efficiency of differentiation. The expression of genes that control muscle metabolism and development was compared for HD/HF patients in both muscle biopsy and in vitro-differentiated myotubes.

resultsThe upregulation of MYH3/MYH8/Myf6 detected in HF skeletal muscle along with metabolic alterations indicates chronic pathological activation of the muscle developmental program. SM-MPC isolated from HD and HF patients represented a mixed population that coexpresses both mesenchymal and myogenic markers and differs from AD-MMSC, BM-MMSC, and IMF-MSC. The functional properties of SM-MPC did not differ between HD and HF patients.

conclusionIn the present work, we demonstrate that the metabolic and functional alterations we detected in skeletal muscle from HF patients do not dramatically affect the functional properties of purified and expanded in vitro SM-MPC. We speculate that skeletal muscle progenitor cells are protected by their niche and under beneficial circumstances could contribute to muscle restoration and prevention and treatment of muscle wasting. The potential new therapeutic strategies of HF-induced skeletal muscle wasting should be targeted on both activation of SM-MPC regeneration potential and improvement of skeletal muscle metabolic status to provide a favorable environment for SM-MPC-driven muscle restoration.

Identifiers

PMID30719048
PMCPMC6335669
OpenAlexW2907139789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.